<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS PharmSciTech</journal-id><journal-id journal-id-type="iso-abbrev">AAPS PharmSciTech</journal-id><journal-id journal-id-type="pmc-domain-id">793</journal-id><journal-id journal-id-type="pmc-domain">aapspharm</journal-id><journal-title-group><journal-title>AAPS PharmSciTech</journal-title></journal-title-group><issn pub-type="epub">1530-9932</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2663660</article-id><article-id pub-id-type="pmcid-ver">PMC2663660.1</article-id><article-id pub-id-type="pmcaid">2663660</article-id><article-id pub-id-type="pmcaiid">2663660</article-id><article-id pub-id-type="pmid">19132537</article-id><article-id pub-id-type="doi">10.1208/s12249-008-9167-0</article-id><article-id pub-id-type="publisher-id">9167</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Polymeric Matrix System for Prolonged Delivery of Tramadol Hydrochloride, Part I: Physicochemical Evaluation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ammar</surname><given-names initials="HO">H. O.</given-names></name><address><phone>+20-124472851</phone><fax>+20-2-3370931</fax><email>husseinammar@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ghorab</surname><given-names initials="M">M.</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>El-Nahhas</surname><given-names initials="SA">S. A.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kamel</surname><given-names initials="R">R.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Pharmaceutical Technology, National Research Center, Dokki, Cairo, Egypt </aff><aff id="Aff2"><label/>Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>1</month><year>2009</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2009</year></pub-date><volume>10</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">177659</issue-id><fpage>7</fpage><lpage>20</lpage><history><date date-type="received"><day>2</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2008</year></date></history><pub-history><event event-type="pmc-release"><date><day>09</day><month>01</month><year>2010</year></date></event><event event-type="pmc-live"><date><day>08</day><month>11</month><year>2010</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2016-04-20 15:07:33.377"><day>20</day><month>04</month><year>2016</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association of Pharmaceutical Scientists 2009</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12249_2008_Article_9167.pdf"/><abstract id="Abs1"><p>Management of moderate or severe chronic pain conditions is the burden of clinicians dealing with patients trying to improve their quality of life and diminish their suffering. Although not a new opioid, tramadol has been recently rediscovered and widely used; this may be due to its favorable chronic safety and dependence profiles together with its high potency. Tramadol is a centrally acting analgesic with half-life of ~6&#160;h; therefore, it requires frequent dosing. It is freely soluble in water; hence, judicious selection of retarding formulations is necessary. The current study is focused on the innovation of a novel, simple, monolayer, easy-to-use, cost-effective, and aesthetically acceptable bioadhesive transdermal delivery system overcoming the defects of the conventional &#8220;patch&#8221; as carrier system for tramadol, ensuring its adequate delivery, along with the physicochemical evaluation of the designed formulations. Monolithic tramadol matrix films of chitosan, different types of Eudragit&#174;, and binary mixtures of both were prepared. As a single-polymer film, chitosan film showed best properties except for somewhat high moisture uptake capacity, insufficient strength and rapid release, and permeation. Polymer blends were monitored in order to optimize both properties and performance. Promising results were obtained, with chitosan&#8211;Eudragit&#174; NE30D (1:1) film showing the most desirable combined, sufficiently rapid as well as prolonged release and permeation profiles along with satisfactory organoleptic and physicochemical properties.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>matrix system</kwd><kwd>pain</kwd><kwd>polymers</kwd><kwd>tramadol hydrochloride</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; American Association of Pharmaceutical Scientists 2009</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>